Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1984)
  2. Solid Tumor Oncology Division (1616)
  3. GSK Faculty (762)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (413)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2092)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (89)
  5. Editorial (80)
  6. Guidelines (36)
  7. Correspondence (24)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1984)
  2. Solid Tumor Oncology Division (1616)
  3. GSK Faculty (762)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (80)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1668)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (209)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4627)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Meeting Abstract

    Bhatia, A.; Moreno, R.; Reiner, A.; Nandakumar, S.; Walch, H.; Thomas, T.; Nicklin, P.; Choi, C.; Skakodub, A.; Malani, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characteristics and clinical outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Walch, H.; Mueller, K.; Eichholz, J.; Khatri, I.; Del Balzo, L.; Kemeny, N.; Imber, B.; Schultz, N.; Foote, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Executive and social functioning in pediatric posterior fossa tumor survivors and healthy controls
    Journal Article

    Ramjan, S.; Levitch, C.; Sands, S.; Kim, S. Y.; Barnett, M.; Bledsoe, J.; Holland, A. A.
    Neuro-Oncology Practice (2023)

    Fulltext@MSK | Save
  • A targetable pathway to eliminate TRA-1-60(+) /TRA-1-81(+) chemoresistant cancer cells
    Journal Article

    Tan, L.; Duan, X.; Mutyala, P.; Zhou, T.; Amin, S.; Zhang, T.; Herbst, B.; Askan, G.; Itkin, T.; Xiang, Z.; more...
    Journal of Molecular Cell Biology (2023)

    Fulltext@MSK | Save
  • Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: Findings from nationally representative data
    Meeting Abstract

    Chan, J. S. K.; Satti, D. I.; Dee, E. C.; Sharma, G.; Virani, S. S.; Liu, T.; Tse, G.
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • Association between immune checkpoint inhibitors and heart failure hospitalizations: A population-based self-controlled case series
    Meeting Abstract

    Chan, J. S. K.; Lee, T. T. L.; Chou, O. H. I.; Lee, Y. H. A.; Dee, E. C.; Ng, K.; Hui, J. M. H.; Leung, F. P.; Wong, W. T.; Liu, T.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV + P) vs chemotherapy (chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
    Meeting Abstract

    Powles, T. B.; Perez Valderrama, B.; Gupta, S.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Iyer, G.; Vulsteke, C.; Park, S. H.; Shin, S. J.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Kelly, W. K.; Danila, D. C.; Lin, C. C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Armstrong, A. J.; Pook, D. W.; Kim, M.; Dorff, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Comparisons of on new-onset prostate cancer in type 2 diabetes mellitus exposed to the SGLT2I and DPP4I: A population-based cohort study
    Meeting Abstract

    Chou, H. I.; Lu, L.; Chung, C. T.; Chan, J. S. K.; Chan, R. N. C.; Lee, Y. H. A.; Dee, E. C.; Ng, K.; Pui, H. H. H.; Lee, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kim, D. W.; Goto, K.; Schram, A.; Hollebecque, A.; Rha, S. Y.; Nishino, K.; Duruisseaux, M.; Umemoto, K.; Park, J. O.; Leighl, N.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save